Multiple Signaling Proteins

The term 'Multiple Signaling Proteins' is a collective and non-specific designation rather than a single molecular entity or a canonical therapeutic target. It refers to a diverse group of proteins—including cell surface receptors, intracellular kinases, and transcription factors—that coordinate cellular responses to environmental stimuli (Source: Nature Reviews Drug Discovery). In pharmacology, this term is frequently used to describe the polypharmacological profile of multi-target drugs, such as multi-kinase inhibitors, which are designed to disrupt several signaling nodes simultaneously to overcome pathway redundancy in complex diseases like cancer (Source: PubMed, PMID: 16955610). While targeting multiple signaling proteins can enhance efficacy and reduce the likelihood of drug resistance, it often results in a higher incidence of off-target toxicities compared to highly selective therapies. Because it lacks a specific molecular definition, it is generally considered an 'incorrect' or 'too broad' entry for structured drug-target databases (Source: ChEMBL).

Other names

Multi-targetPolypharmacological targetsMultiple kinasesSignal transduction proteins

Simultaneous inhibition or modulation of multiple distinct signaling pathways, typically through the binding of conserved domains (such as ATP-binding pockets) across different protein families.